Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Psychoses, Drug

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Psychoses, Drug in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abi-Dargham, A; Baldwin, RM; Charney, DS; D'Souza, CD; Erdos, J; Fingado, C; Gil, R; Innis, RB; Krystal, JH; Laruelle, M; McCance, E; Rosenblatt, W; Seibyl, JP; van Dyck, CH; Zoghbi, SS1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Psychoses, Drug

ArticleYear
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Aug-20, Volume: 93, Issue:17

    Topics: Adult; Amphetamine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Humans; Male; Papio; Psychoses, Substance-Induced; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon

1996